Open Access
Research Article

Table 2.

Administered tablet doses per individual dog in treated group.

Group 2 dogs
Tablets to be administered (g)
Animal ID Body weight (kg) 0.5 1 2 4 8 Afoxolaner dose (mg) Milbemycin dose (mg)
1FD 220 16.62 1 0 1 0 0 46.88 9.38
2AC DC2 19.26 0 1 1 0 0 56.25 11.25
4DA C4C 17.20 1 0 1 0 0 46.88 9.38
5A3 1B0 12.40 0 0 1 0 0 37.5 7.5
5B3 502 16.36 1 0 1 0 0 46.88 9.38
5CB 26C 12.80 0 0 1 0 0 37.5 7.5
5E0 B03 14.60 0 0 1 0 0 37.5 7.5
6D5 307 18.40 1 0 1 0 0 46.88 9.38
B2B 55A 17.80 1 0 1 0 0 46.88 9.38
E19 260 16.80 1 0 1 0 0 46.88 9.38
NexGard spectra®
Size of chewable tablets (g)
Afoxolaner (mg)
Milbemycin oxime (mg)
Chewable tablets for dogs 2.0 kg–3.5 kg 0.5 9.38 1.88
Chewable tablets for dogs > 3.5 kg–7.5 kg 1 18.75 3.75
Chewable tablets for dogs > 7.5 kg–15.0 kg 2 37.50 7.50
Chewable tablets for dogs > 15.0 kg–30.0 kg 4 75.00 15.00
Chewable tablets for dogs > 30.0 kg–60.0 kg 8 150.00 30.00

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.